MPM BioImpact LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 285 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
MPM BioImpact LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,221,485
-22.5%
544,6390.0%4.60%
+2.8%
Q2 2023$22,210,378
+4.1%
544,639
-4.9%
4.47%
-19.3%
Q1 2023$21,335,547
+34.3%
572,459
+25.7%
5.54%
+34.5%
Q4 2022$15,883,254
-24.2%
455,238
+21.6%
4.12%
-16.9%
Q3 2022$20,952,000
+35.2%
374,409
+25.0%
4.96%
+15.3%
Q2 2022$15,497,000
+33.8%
299,409
+87.8%
4.30%
+38.5%
Q1 2022$11,584,000
-39.0%
159,409
-0.7%
3.11%
-10.1%
Q4 2021$18,981,000
-13.0%
160,527
-1.3%
3.46%
+2.2%
Q3 2021$21,815,000
+212.9%
162,620
+26.9%
3.38%
+462.1%
Q4 2020$6,972,000128,1620.60%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders